Alpha Profiles · Company Profile

NOVARTIS AG

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/novartis-ag

Entity: Public listing published
Primary listing: SIX: NOVN
Verification: Partially verified
Last reviewed: 2026-09-13T04:47:39.571048+00:00

Overview

Alpha's canonical identity and public leadership record for NOVARTIS AG.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

14 public records

Aharon (Ronny) Gal

Chief Strategy & Growth Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Charlotte Pamer-Wieser

Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Board of DirectorsSep 1, 2026

Fiona H. Marshall

President, Biomedical Research

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Karen L. Hale

Chief Legal and Compliance Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Lutz Hegemann

President, Global Health and Swiss Country Affairs

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Michelle Weese

Chief Corporate Affairs Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Mukul Mehta

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Patrick Horber

President, International

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Rob Kowalski

Chief People & Organization Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Shreeram Aradhye

President, Development, and Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Steffen Lang

President, Operations

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Teresa Jose

Chief Audit Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Vasant (Vas) Narasimhan

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Victor Bulto

President, US

State: confirmed
Effective: Date not stated
Confidence: 90%
Evidence: Novartis AG Executive CommitteeSep 1, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.